Cellectis (CLLS) EBT Margin (QoQ) (2015 - 2026)
Cellectis (CLLS) EBT Margin (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68,120.00 |
| Dec 31, 2025 | -89,777.00 |
| Sep 30, 2025 | -2,988.00 |
| Jun 30, 2025 | 7,140.00 |
| Mar 31, 2025 | 34,984.00 |
| Dec 31, 2024 | -37,518.00 |
| Sep 30, 2024 | -4,960.00 |
| Jun 30, 2024 | -16,020.00 |
| Mar 31, 2024 | 3.13 Mn |
| Dec 31, 2023 | -602,514.00 |
| Sep 30, 2023 | -559,433.00 |
| Jun 30, 2023 | -688,698.00 |
| Mar 31, 2023 | -1.26 Mn |
| Dec 31, 2022 | 1.33 Mn |
| Sep 30, 2022 | -1.22 Mn |
| Jun 30, 2022 | -85,839.00 |
| Mar 31, 2022 | -26,871.00 |
| Dec 31, 2021 | 46,726.00 |
| Sep 30, 2021 | -21,240.00 |
| Jun 30, 2021 | -28,446.00 |